|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q1 FY2025
As of Mar 31, 2025
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Assets of discontinued operations | ||||||||||||||||||||
| Deferred finance cost | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangibles assets, net | ||||||||||||||||||||
| Investment in Salt Tequila USA, LLC | ||||||||||||||||||||
| Water rights | ||||||||||||||||||||
| Investment in Avicanna, net | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Property and equipment | ||||||||||||||||||||
| Assets of discounted operations | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Right of use liability, current portion | ||||||||||||||||||||
| Related party notes payable | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Notes payable, net of discounts | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Liability to issue shares | ||||||||||||||||||||
| Stockholder advances | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Notes payable, net of discounts | ||||||||||||||||||||
| Right of use liability – net of current portion | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Series A Preferred Stocks | ||||||||||||||||||||
| Series A 1 Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Total preferred stock value | ||||||||||||||||||||
| Common Stock, $0.001 par, 100,000,000 shares authorized, 4,127,220 shares outstanding at June 30, 2026 and 749,450 shares outstanding at December 31, 2025 | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated other comprehensive income / (loss) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
